News

Unilife and Independent Medical (IMCO) have entered into a preferred, non-exclusive marketing program for the sale of Unitract 1mL syringes to US healthcare facilities. Unilife considers IMCO to

Amakem focuses on making drugs safer by limiting or avoiding systemic exposure, thereby reducing side effects caused in non target organs. Amakem CSO Dirk Leysen said that they

Merck Serono said that the marketing authorisations enabling commercial sales in the individual countries are expected over the next several months. Saizen solution for injection is a liquid

Importantly, rates of bleeding were similar to warfarin, and bleeding events most concerning to physicians and patients, including intracranial hemorrhage, critical organ bleed, and bleeding-related death, were significantly

The Food Standards Agency has issued a Product Withdrawal Information Notice in this regard. The product batches produced before November 2010 that are being withdrawn from sale include

3SBio has posted a net income of $3.94m for the third quarter 2010, or $0.03 per diluted share, compared to net income of $3.35m, or $0.02 per diluted

Hospira‘s Gemcitabine is approved by the US Food and Drug Administration (FDA) for treatment of a variety of cancers. Hospira claimed that it will be the first company

DelRx has proprietary platform drug delivery technology for transmucosal administration of large molecule drugs as a liquid dispersion, e.g., peptides like insulin, monoclonal antibodies, hormones, vaccines and other

Sunesis Pharma said that Vosaroxin is an anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. According